Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jul 9;9(7):e027942.
doi: 10.1136/bmjopen-2018-027942.

Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)

Affiliations

Implementation of the Symptom Navi © Programme for cancer patients in the Swiss outpatient setting: a study protocol for a cluster randomised pilot study (Symptom Navi© Pilot Study)

Marika Bana et al. BMJ Open. .

Abstract

Introduction: Self-management interventions show promising results on symptom outcomes and self-management behaviours. The Symptom Navi© Programme (SN©P) is a nurse-led intervention supporting patients' symptom self-management during anticancer treatment. It consists of written patient information (Symptom Navi© Flyers (SN©Flyers)), semistructured consultations and a training manual for nurses.

Methods and analysis: This pilot study will evaluate the implementation of the SN©P based on the Reach Effectiveness-Adoption Implementation Maintenance framework at Swiss outpatient cancer centres. We will use a cluster-randomised design and randomise the nine participating centres to the intervention or usual care group. We expect to include 140 adult cancer patients receiving first-line systemic anticancer treatment. Trained nurses at the intervention clusters will provide at least two semistructured consultations with the involvement of SN©Flyers. Outcomes include patients' accrual and retention rates, patient-reported interference of symptoms with daily functions, symptom burden, perceived self-efficacy, quality of nursing care, nurse-reported facilitators and barriers of adopting the programme, nurses' fidelity of providing the intervention as intended, and patients' safety (patients timely reporting of severe symptoms). We will use validated questionnaires for patient-reported outcomes, focus group interviews with nurses and individual interviews with oncologists. Linear mixed models will be used to analyse patient-reported outcomes. Focus group and individual interviews will be analysed by thematic analysis.

Ethics and dissemination: The Symptom Navi© Pilot Study has been reviewed and approved by Swiss Ethic Committee Bern (KEK-BE: 2017-00020). Results of the study will be disseminated in peer-reviewed journal and at scientific conferences.

Trial registration number: NCT03649984; Pre-results.

Keywords: Nurses/nursing; RE-AIM framework; implementation research; self-efficacy; symptom self-management.

PubMed Disclaimer

Conflict of interest statement

Competing interests: SP has received education grants, provided consultation, attended advisory boards and/or provided lectures for: Abbvie, Amgen, AstraZeneca, Bayer, Biocartis, BoehringerIngelheim, Bristol-Myers Squibb, Clovis, Daiichi Sankyo, Debiopharm, Eli Lilly, F Hoffmann-La Roche, Foundation Medicine, Illumina, Janssen, Merck Sharp and Dohme, Merck Serono, Merrimack, Novartis, Pharma Mar, Pfizer, Regeneron, Sanofi, Seattle Genetics and Takeda , from whom she has received honoraria. ME received education grants, provided consultation, attended advisory boards and/or provided lectures for: Vifor, Roche, and Bristol-Myers Squibb. All other authors have no competing interests to declare.

Figures

Figure 1
Figure 1
Study flowchart for the Symptom Navi© Pilot Study with included patient timeline. *Every patient enrolled for the pilot study will start with SN©P and will be followed by two semistructured nurse-led consultations. **Semistructured nurse-led consultations take place during first and second scheduled treatment application at the outpatient centres of the intervention arm. BL, baseline.

Similar articles

Cited by

References

    1. Arndt V, Feller A, Hauri D, et al. . Schweizerischer Krebsbericht 2015, Stand und Entwicklungen. Neuchâtel: Bundesamt für Statistik (BFS), Nationales Institut für Krebsepidemiologie und -registrierung (NICER), Schweizer Kinderkrebsregister, 2016. https://www.bfs.admin.ch/bfs/de/home/statistiken/kataloge-datenbanken/me....
    1. Brédart A, Kop JL, Efficace F, et al. . Quality of care in the oncology outpatient setting from patients' perspective: a systematic review of questionnaires' content and psychometric performance. Psychooncology 2015;24:382–94. 10.1002/pon.3661 - DOI - PubMed
    1. Deshields TL, Potter P, Olsen S, et al. . The persistence of symptom burden: symptom experience and quality of life of cancer patients across one year. Support Care Cancer 2014;22:1089–96. 10.1007/s00520-013-2049-3 - DOI - PMC - PubMed
    1. Cleeland CS, Zhao F, Chang VT, et al. . The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the Eastern Cooperative Oncology Group Symptom Outcomes and Practice Patterns study. Cancer 2013;119:4333–40. 10.1002/cncr.28376 - DOI - PMC - PubMed
    1. Giesinger JM, Wintner LM, Zabernigg A, et al. . Assessing quality of life on the day of chemotherapy administration underestimates patients' true symptom burden. BMC Cancer 2014;14:758 10.1186/1471-2407-14-758 - DOI - PMC - PubMed

Publication types

Associated data